Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPTIFIBATIDE vs EPTINEZUMAB-JJMR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPTIFIBATIDE vs EPTINEZUMAB-JJMR: Safety Overview

Metric EPTIFIBATIDE EPTINEZUMAB-JJMR
Total FAERS Reports 462 7,165
Deaths Reported 57 42
Death Rate 12.3% 0.6%
Hospitalizations 143 438
Average Patient Age 57.2 yrs 50.0 yrs
% Female Patients 30.9% 85.5%
FDA Approval Date Apr 18, 2017 N/A
Manufacturer Slate Run Pharmaceuticals, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription